1. Home
  2. FEMY vs NAAS Comparison

FEMY vs NAAS Comparison

Compare FEMY & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.65

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Logo NaaS Technology Inc.

NAAS

NaaS Technology Inc.

HOLD

Current Price

$3.20

Market Cap

35.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
NAAS
Founded
2004
2019
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.4M
35.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
FEMY
NAAS
Price
$0.65
$3.20
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.83
N/A
AVG Volume (30 Days)
1.3M
23.6K
Earning Date
11-14-2025
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,061,502.00
$21,817,052.00
Revenue This Year
$64.02
$378.49
Revenue Next Year
$147.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.53
N/A
52 Week Low
$0.31
$1.96
52 Week High
$1.80
$40.32

Technical Indicators

Market Signals
Indicator
FEMY
NAAS
Relative Strength Index (RSI) 45.02 42.96
Support Level $0.60 $3.01
Resistance Level $0.73 $3.44
Average True Range (ATR) 0.06 0.17
MACD 0.01 0.01
Stochastic Oscillator 45.12 49.08

Price Performance

Historical Comparison
FEMY
NAAS

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

Share on Social Networks: